Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.54 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30628176 | 0.85 | TYR (0.47) | TYRNR1H4MAOBPTGS2MAPT | |
| SCHEMBL27013667 | 0.82 | PTPN1 (0.49) | TYRGAAPTPN1 | |
| SCHEMBL29702142 | 0.82 | PTPN1 (0.49) | TYRGAAPTPN1 | |
| SCHEMBL29573454 | 0.81 | TYR (0.57) | TYRNR1H4MAOBMAPTRAB9A | |
| SCHEMBL4320833 | 0.81 | TYR (0.57) | TYRNR1H4MAOBMAPTRAB9A | |
| SCHEMBL4549102 | 0.78 | TYR (0.55) | TYRNR1H4MAOBKDM4EMIF | |
| SCHEMBL612956 | 0.76 | MAOB (0.49) | TYRNR1H4MAOBPTGS2MAPT | |
| SCHEMBL6498965 | 0.75 | NR1H4 (0.45) | TYRNR1H4MAOBMAPTKDM4E | |
| SCHEMBL952469 | 0.74 | NR1H4 (0.54) | TYRNR1H4MAOBPTGS2MAPT | |
| SCHEMBL13704162 | 0.73 | TYR (0.38) | TYRNR1H4ARMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190142940-A1 | Method and system for effecting changes in pigmented tissue | MOAZED KAMBIZ THOMAS (US) | 2019-05-16 | — | — | US | claimed |
| US-20120207809-A1 | Method and system for effecting changes in pigmented tissue | MOAZED KAMBIZ THOMAS (US) | 2012-08-16 | — | — | US | claimed |
| US-20120076848-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2012-03-29 | — | — | US | claimed |
| US-20110280909-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-11-17 | — | — | US | claimed |
| WO-2011011065-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-01-27 | — | — | WO | claimed |
| WO-2010087983-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2010-08-05 | — | — | WO | claimed |
| JP-11322530-A | — | — | None | — | — | JP | disclosed |
| CN-120154539-A | Camellia polypeptide composition with anti-wrinkle, repairing and brightening effects and preparation method and application thereof | 上海林清轩生物科技股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-115337235-B | Multiple whitening pathway composition containing safflower camellia extract | 上海林清轩生物科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-115337235-A | Multi-whitening-path composition containing camellia chrysantha extract | 上海林清轩生物科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| US-20190142940-A1 | Method and system for effecting changes in pigmented tissue | MOAZED KAMBIZ THOMAS (US) | 2019-05-16 | — | — | US | disclosed |
| US-20170334842-A1 | INHIBITORS OF THE MITF MOLECULAR PATHWAY | UNIVERSITY OF KANSAS | 2017-11-23 | — | — | US | disclosed |
| US-9744237-B2 | Method and system for effecting changes in pigmented tissue | MOAZED KAMBIZ THOMAS (US) | 2017-08-29 | — | — | US | disclosed |
| US-20110301105-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2011-12-08 | — | — | US | disclosed |
| US-20110280909-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-11-17 | — | — | US | disclosed |
| US-20110129136-A1 | Method And System For Screening Of A To-Be-Analyzed Candidate As A Skin-Whitening Agent | NATIONAL SUN YAT-SEN UNIVERSITY (TW) | 2011-06-02 | — | — | US | disclosed |
| WO-2011011065-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-01-27 | — | — | WO | disclosed |
| WO-2010087983-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2010-08-05 | — | — | WO | disclosed |
| WO-2010039679-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2010-04-08 | — | — | WO | disclosed |
| JP-H11322530-A | SKIN-BEAUTIFYING PREPARATION FOR EXTERNAL USE FOR SKIN | POLA CHEM IND INC | 1999-11-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334842-A1 | INHIBITORS OF THE MITF MOLECULAR PATHWAY | MITF, TFEB, TYR | TYR 3/4885NR1H4 3243/4885MAOB 666/4885 |
| US-20110301105-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | MKI67, KRT18, PROX1 | TYR 141/4885NR1H4 1800/4885MAOB 3896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.